BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 31300517)

  • 21. Organoids from the Human Fetal and Adult Pancreas.
    Balak JRA; Juksar J; Carlotti F; Lo Nigro A; de Koning EJP
    Curr Diab Rep; 2019 Dec; 19(12):160. PubMed ID: 31828551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease modeling, and toxicology testing.
    Salas-Silva S; Kim Y; Kim TH; Kim M; Seo D; Choi J; Factor VM; Seo HR; Song Y; Choi GS; Jung YK; Kim K; Lee KG; Jeong J; Shin JH; Choi D
    Biomaterials; 2023 Dec; 303():122360. PubMed ID: 38465578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
    Grassi L; Alfonsi R; Francescangeli F; Signore M; De Angelis ML; Addario A; Costantini M; Flex E; Ciolfi A; Pizzi S; Bruselles A; Pallocca M; Simone G; Haoui M; Falchi M; Milella M; Sentinelli S; Di Matteo P; Stellacci E; Gallucci M; Muto G; Tartaglia M; De Maria R; Bonci D
    Cell Death Dis; 2019 Feb; 10(3):201. PubMed ID: 30814510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling Liver Development and Disease in a Dish.
    Iqbal W; Wang Y; Sun P; Zhou X
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From Spheroids to Organoids: The Next Generation of Model Systems of Human Cardiac Regeneration in a Dish.
    Scalise M; Marino F; Salerno L; Cianflone E; Molinaro C; Salerno N; De Angelis A; Viglietto G; Urbanek K; Torella D
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use and application of 3D-organoid technology.
    Artegiani B; Clevers H
    Hum Mol Genet; 2018 Aug; 27(R2):R99-R107. PubMed ID: 29796608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-dimensional in vitro tissue culture models of brain organoids.
    Gong J; Meng T; Yang J; Hu N; Zhao H; Tian T
    Exp Neurol; 2021 May; 339():113619. PubMed ID: 33497645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current concepts in tumour-derived organoids.
    Porter RJ; Murray GI; McLean MH
    Br J Cancer; 2020 Oct; 123(8):1209-1218. PubMed ID: 32728094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney organoids in translational medicine: Disease modeling and regenerative medicine.
    Miyoshi T; Hiratsuka K; Saiz EG; Morizane R
    Dev Dyn; 2020 Jan; 249(1):34-45. PubMed ID: 30843293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advances in Generation of In Vitro Cardiac Organoids.
    Sahara M
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human organoids in basic research and clinical applications.
    Tang XY; Wu S; Wang D; Chu C; Hong Y; Tao M; Hu H; Xu M; Guo X; Liu Y
    Signal Transduct Target Ther; 2022 May; 7(1):168. PubMed ID: 35610212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system.
    Wang Y; Wang H; Deng P; Chen W; Guo Y; Tao T; Qin J
    Lab Chip; 2018 Dec; 18(23):3606-3616. PubMed ID: 30357207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organoids to model liver disease.
    Nuciforo S; Heim MH
    JHEP Rep; 2021 Feb; 3(1):100198. PubMed ID: 33241206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reverse engineering liver buds through self-driven condensation and organization towards medical application.
    Shinozawa T; Yoshikawa HY; Takebe T
    Dev Biol; 2016 Dec; 420(2):221-229. PubMed ID: 27364470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pluripotent stem cell-derived kidney organoids: An in vivo-like in vitro technology.
    Schutgens F; Verhaar MC; Rookmaaker MB
    Eur J Pharmacol; 2016 Nov; 790():12-20. PubMed ID: 27375081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organoid Models for Salivary Gland Biology and Regenerative Medicine.
    Zhao C; Meng C; Cui N; Sha J; Sun L; Zhu D
    Stem Cells Int; 2021; 2021():9922597. PubMed ID: 34497651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organogenesis in a dish: modeling development and disease using organoid technologies.
    Lancaster MA; Knoblich JA
    Science; 2014 Jul; 345(6194):1247125. PubMed ID: 25035496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of organoids for personalized medicine.
    Perkhofer L; Frappart PO; Müller M; Kleger A
    Per Med; 2018 Nov; 15(6):461-465. PubMed ID: 30418092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organoid technology for brain and therapeutics research.
    Wang Z; Wang SN; Xu TY; Miao ZW; Su DF; Miao CY
    CNS Neurosci Ther; 2017 Oct; 23(10):771-778. PubMed ID: 28884977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.